Coghill, David R. http://orcid.org/0000-0003-3017-9737
Werner-Kiechle, Tamara
Farahbakhshian, Sepehr
Bliss, Caleb
Robertson, Brigitte
Huss, Michael
Funding for this research was provided by:
Shire International GmbH
Article History
Received: 10 July 2019
Accepted: 24 February 2020
First Online: 20 July 2020
Compliance with ethical standards
:
: C. Bliss, S. Farahbakhshian, B. Robertson and T. Werner-Kiechle are employees of Shire, a member of the Takeda group of companies, and are Takeda stock owners. The following authors have received compensation for serving as consultants or speakers, or they or the institutions they work for have received research support or royalties from the companies or organizations indicated: DR Coghill (Eli Lilly, Janssen-Cilag, Medice, Novartis, Oxford University Press and Shire [a member of the Takeda group of companies]); M Huss (Actelion, Eli Lilly, Engelhard Arzneimittel, Janssen-Cilag, Lundbeck, Medice, Novartis, Shire [a member of the Takeda group of companies] and Steiner Arzneimittel).